Examination Report |
1 | Additional Representation Sheet | 15 Mar 2012 |
1 | TM-1 | 15 Mar 2012 |
10 | Hearing Notice | 08 Aug 2024 |
2 | Additional Representation Sheet | 15 Mar 2012 |
2 | TM-1 | 15 Mar 2012 |
3 | Reply to Exam Report (MIS-R) | 28 Apr 2016 |
4 | Journal Copy | 27 Feb 2017 |
5 | TM-O(NOTICE OF OPPOSITION) | 22 May 2017 |
6 | TM-O(NOTICE OF OPPOSITION) | 23 Jun 2017 |
7 | Forwarding Letter for TM-5 | 10 Jul 2017 |
8 | Forwarding Letter for TM-5 | 24 Aug 2017 |
9 | Hearing Notice | 08 Aug 2024 |
1 | Dispatching of Examination Report for : 2299544 | 2758895 | 1380029 | 12 Jan 2016 |
2 | Abandoned Order for Application No 2299544 | 3315221 | 1692912 | 30 Mar 2016 |
3 | Opposition Notice | 4911478 | 04 Jul 2017 | |
4 | Opposition Notice | 5023679 | 09 Aug 2017 | |
5 | Opposition Counter Statement | 5211183 | 2218985 | 10 Oct 2017 |
6 | Opposition Counter Statement | 5344143 | 2263603 | 06 Nov 2017 |
The application for Rapidocin was made on 15 March 2012.
The trademark applicant for Rapidocin is MINOVA LIFE SCIENCES.
Rapidocin is applied in class(es) 5.
Application for Rapidocin is on Opposed stage.
Application Id allotted to Rapidocin is 2299544.
Trademark agent or attorney for the application is G. Paramesh.
Rapidocin filed with the Intellectual property office as a WORD.